Study protocol DFCI IRB and the Hospital Sírio-Libanês IRB approved the protocol for this study. Patients provided written informed consent according to CARE guidelines and in compliance with the Declaration of Helsinki principles. Cell lines and drugs The PC-9 NSCLC cell line harboring EGFR mutant (del E746_A750) was originally established in Tokyo Medical University and obtained from Dr. Nishio Kazuto (Kindai University, Osaka, Japan) in 2005, and confirmed by fingerprinting.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Arrien A.
Contact Arrien A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack